These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33655579)

  • 1. Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes.
    Romagnoli A; Santoleri F; Costantini A
    Int J Clin Pract; 2021 Jun; 75(6):e14120. PubMed ID: 33655579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 on chronic therapies: the Pescara (ASL) local health authority experience in Italy.
    Romagnoli A; Santoleri F; Costantini A
    Curr Med Res Opin; 2022 Feb; 38(2):311-316. PubMed ID: 34850662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy.
    Colombo GL; Agabiti-Rosei E; Margonato A; Mencacci C; Montecucco CM; Trevisan R; Catapano AL
    Atheroscler Suppl; 2016 Jun; 21():1-8. PubMed ID: 26948872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
    Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
    Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [One year persistence of metformin monotherapy versus metformin/sitagliptin fixed dose combination].
    Simonyi G; Ferenci T
    Orv Hetil; 2016 Apr; 157(16):618-22. PubMed ID: 27063429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs. loose-dose combination of oral anti-diabetes drugs.
    Lokhandwala T; Smith N; Sternhufvud C; Sörstadius E; Lee WC; Mukherjee J
    J Med Econ; 2016; 19(3):203-12. PubMed ID: 26473990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.
    Balkrishnan R; Rajagopalan R; Shenolikar RA; Camacho FT; Whitmire JT; Anderson RT
    Curr Med Res Opin; 2004 Oct; 20(10):1633-40. PubMed ID: 15462696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
    McGovern A; Tippu Z; Hinton W; Munro N; Whyte M; de Lusignan S
    BMJ Open; 2016 Feb; 6(2):e010469. PubMed ID: 26928029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United States.
    Cai J; Wang Y; Baser O; Xie L; Chow W
    J Med Econ; 2016 Dec; 19(12):1175-1186. PubMed ID: 27356271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of various measures for assessing medication refill adherence using prescription data.
    Vink NM; Klungel OH; Stolk RP; Denig P
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):159-65. PubMed ID: 19109809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
    Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
    Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Banerjee A; Benedetto V; Gichuru P; Burnell J; Antoniou S; Schilling RJ; Strain WD; Ryan R; Watkins C; Marshall T; Sutton CJ
    Heart; 2020 Jan; 106(2):119-126. PubMed ID: 31601729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes.
    Ogundipe O; Mazidi M; Chin KL; Gor D; McGovern A; Sahle BW; Jermendy G; Korhonen MJ; Appiah B; Ademi Z; De Bruin ML; Liew D; Ofori-Asenso R
    Acta Diabetol; 2021 Jan; 58(1):39-46. PubMed ID: 32809070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study.
    Nishimura R; Kato H; Kisanuki K; Oh A; Hiroi S; Onishi Y; Guelfucci F; Shimasaki Y
    BMJ Open; 2019 Mar; 9(3):e025806. PubMed ID: 30826768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
    Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
    Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea.
    Kim JA; Kim ES; Lee EK
    Medicine (Baltimore); 2017 Apr; 96(14):e6577. PubMed ID: 28383439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
    Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
    Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
    Karlsson SA; Hero C; Svensson AM; Franzén S; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Eliasson B; Andersson Sundell K
    BMJ Open; 2018 Mar; 8(3):e020309. PubMed ID: 29602853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.